I. Gaertner

970 total citations
13 papers, 715 citations indexed

About

I. Gaertner is a scholar working on Pharmacology, Pharmacology and Molecular Biology. According to data from OpenAlex, I. Gaertner has authored 13 papers receiving a total of 715 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 4 papers in Pharmacology and 3 papers in Molecular Biology. Recurrent topics in I. Gaertner's work include Treatment of Major Depression (4 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Alcoholism and Thiamine Deficiency (2 papers). I. Gaertner is often cited by papers focused on Treatment of Major Depression (4 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Alcoholism and Thiamine Deficiency (2 papers). I. Gaertner collaborates with scholars based in Germany, Switzerland and Austria. I. Gaertner's co-authors include Christoph Hiemke, Gerald Zernig, Gabriel Eckermann, Pierre Baumann, Peter Riederer, S. Ulrich, B. Müller‐Oerlinghausen, G. Laux, Michael D. Köhnke and Sandra Schick and has published in prestigious journals such as Biological Psychiatry, Neuropsychopharmacology and Journal of Neural Transmission.

In The Last Decade

I. Gaertner

13 papers receiving 696 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Gaertner Germany 12 320 171 156 149 110 13 715
S A Volpicelli United States 8 447 1.4× 128 0.7× 194 1.2× 94 0.6× 143 1.3× 8 790
C. Barnas Austria 19 700 2.2× 197 1.2× 166 1.1× 168 1.1× 111 1.0× 61 1.2k
Lawrence J. Albers United States 16 286 0.9× 162 0.9× 199 1.3× 181 1.2× 150 1.4× 26 781
Frank Larsen Denmark 17 248 0.8× 202 1.2× 162 1.0× 126 0.8× 74 0.7× 41 736
Bruno Pfuhlmann Germany 21 501 1.6× 229 1.3× 86 0.6× 74 0.5× 122 1.1× 76 1.1k
Gabriel Eckermann Germany 9 385 1.2× 213 1.2× 94 0.6× 123 0.8× 111 1.0× 24 766
Jeffrey Paul United States 16 188 0.6× 242 1.4× 126 0.8× 171 1.1× 108 1.0× 29 700
Niels‐Erik Larsen Denmark 20 384 1.2× 245 1.4× 96 0.6× 94 0.6× 171 1.6× 44 1.1k
Stanley W. Carson United States 21 159 0.5× 181 1.1× 98 0.6× 223 1.5× 211 1.9× 54 1.3k
K. Otani Japan 18 432 1.4× 251 1.5× 279 1.8× 257 1.7× 274 2.5× 49 1.1k

Countries citing papers authored by I. Gaertner

Since Specialization
Citations

This map shows the geographic impact of I. Gaertner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Gaertner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Gaertner more than expected).

Fields of papers citing papers by I. Gaertner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Gaertner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Gaertner. The network helps show where I. Gaertner may publish in the future.

Co-authorship network of co-authors of I. Gaertner

This figure shows the co-authorship network connecting the top 25 collaborators of I. Gaertner. A scholar is included among the top collaborators of I. Gaertner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Gaertner. I. Gaertner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Köhnke, Michael D., Anil Batra, Werner Kolb, et al.. (2005). ASSOCIATION OF THE DOPAMINE TRANSPORTER GENE WITH ALCOHOLISM. Alcohol and Alcoholism. 40(5). 339–342. 52 indexed citations
2.
Baumann, Pierre, Christoph Hiemke, S. Ulrich, et al.. (2004). Therapeutic Monitoring of Psychotropic Drugs. Therapeutic Drug Monitoring. 26(2). 167–170. 34 indexed citations
3.
Baumann, Pierre, Christoph Hiemke, S. Ulrich, et al.. (2004). The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry. Pharmacopsychiatry. 37(6). 243–265. 295 indexed citations
4.
Baumann, Pierre, Christoph Hiemke, S. Ulrich, et al.. (2004). Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“. Pharmacopsychiatry. 36(5). 1 indexed citations
5.
Müller, Matthias J., Aleksandra Dragičević, I. Gaertner, et al.. (2003). Therapeutic Drug Monitoring of Tricyclic Antidepressants: How Does it Work under Clinical Conditions?. Pharmacopsychiatry. 36(3). 98–104. 45 indexed citations
6.
Köhnke, Michael D., et al.. (2002). Cytochrome P450 2D6 Deficiency and its Clinical Relevance in a Patient Treated with Risperidone. Pharmacopsychiatry. 35(3). 116–118. 26 indexed citations
7.
Köhnke, Michael D., Cyrus P. Zabetian, George Anderson, et al.. (2002). A genotype-controlled analysis of plasma dopamine β-hydroxylase in healthy and alcoholic subjects: evidence for alcohol-related differences in noradrenergic function. Biological Psychiatry. 52(12). 1151–1158. 63 indexed citations
8.
Köhnke, Michael D., Werner Kolb, Sandra Schick, et al.. (2002). Plasma Homovanillic Acid: A Significant Association with Alcoholism is Independent of a Functional Polymorphism of the Human Catechol-O-Methyltransferase Gene. Neuropsychopharmacology. 28(5). 1004–1010. 30 indexed citations
9.
Schick, Sandra, et al.. (2002). Severity of alcohol withdrawal symptoms and the T1128C polymorphism of the neuropeptide Y gene.. Journal of Neural Transmission. 109(11). 1423–1429. 32 indexed citations
10.
Eschweiler, Gerhard W., et al.. (2002). Heart-Rate Variability (HRV) in the ECG Trace of Routine EEGs: Fast Monitoring for the Anticholinergic Effects of Clozapine and Olanzapine?. Pharmacopsychiatry. 35(3). 96–100. 19 indexed citations
11.
Gaertner, I., et al.. (2001). Relevance of Liver Enzyme Elevations With Four Different Neuroleptics: A Retrospective Review of 7,263 Treatment Courses. Journal of Clinical Psychopharmacology. 21(2). 215–222. 42 indexed citations
12.
Gaertner, I., et al.. (2001). Therapeutic Drug Monitoring of Clozapine in Relapse Prevention: A Five-Year Prospective Study. Journal of Clinical Psychopharmacology. 21(3). 305–310. 48 indexed citations
13.
Dachtler, Markus, et al.. (2001). Isolation and identification of clozapine metabolites in patient urine.. PubMed. 29(6). 923–31. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S A Volpicelli Breakdown of academic impact, for papers by C. Barnas Breakdown of academic impact, for papers by Lawrence J. Albers Breakdown of academic impact, for papers by Frank Larsen Breakdown of academic impact, for papers by Bruno Pfuhlmann Breakdown of academic impact, for papers by Gabriel Eckermann Breakdown of academic impact, for papers by Jeffrey Paul Breakdown of academic impact, for papers by Niels‐Erik Larsen Breakdown of academic impact, for papers by Stanley W. Carson Breakdown of academic impact, for papers by K. Otani
Rankless by CCL
2026